Premium Information is available for this item - Upgrade for $1 a day
6505-01-078-0669
Hydralazine Hydrochloride And Hydrochlorothiazide Capsules
6505010780669 010780669 APRESAZIDE NDC00083-0139-30 3131
May 2023
7
Marketplace 6505-01-078-0669
Request a Quotation from participating marketplace vendors
Updated Every Day Updated Every Day 
Updated Every Day Related Documents 6505-01-078-0669 3+ Documents (More...)
May 2023 NATO Update Count 7 NATO Data Quality NSN 6505-01-078-0669 (Generic Image) 1/1 1.
RQST NE Updated Every Day 6505-01-078-0669 RQST Updated Every Day 6505-01-078-0669 RQST NE Related
( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-078-81386505010788138010788138,APRESAZIDE
6505010780669 010780669,APRESAZIDE 6505-01-078-0669Hydralazine Hydrochloride And Hydrochlorothiazide
Restrictions 6505-01-078-0669
6505-01-078-0669 is a Hydralazine Hydrochloride And Hydrochlorothiazide Capsules that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 6505-01-078-0669
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-078-0669
- MOE Rule:
- V540
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-078-0669
- Part Number
- Manufacturer
- Status
- NDC00083-0139-30
- Manufacturer
- 04482 - Ciba-Geigy Corp (Active)
- Primary Buy
- Primary Buy
- 3131
- 04482 - Ciba-Geigy Corp (Active)
- Primary Buy
- Primary Buy
- APRESAZIDE
- 04482 - Ciba-Geigy Corp (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-01-078-0669
- Characteristic
- Specifications
- FIIG
- Specifications
- A510U0
- Active Medicament Medicinal Strength [AKJA]
- 25.000 Milligrams Hydralazine Hydrochloride Active Ingredient And 25.000 Milligrams Hydrochlorothiazide Active Ingredient
- Capsule Primary Container Content Quantity [CYLZ]
- 100.000
- Capsule Content Form [CQLS]
- Any Acceptable
- Capsule Type [AKJC]
- Any Acceptable
- Primary Container Type [CQCT]
- Bottle
NATO Stock Numbers Related to 6505-01-078-0669
Freight Information 6505-01-078-0669
6505-01-078-0669 has freight characteristics.. 6505-01-078-0669 has a variance between NMFC and UFC when transported by rail and the description should be consulted.